Preprint coverage: Vaccinating adolescents in England: a risk-benefit analysis
12 August 2021
Preprint paper by Prof. Christina Pagel UCL, Prof. Deepti Gurdasani QM, and colleagues "Vaccinating adolescents in England: a risk-benefit analysis" has been covered by news headlines.
The UK JCVI committee recently announced that vaccines would not be offered to all 12-17 year olds, as the potential risks were not outweighed by the benefits. Here, we offer a quantitative risk-benefit analysis of vaccines among 12-17 year olds in England, showing that the benefits of vaccination greatly outweigh risks among12-17 year olds in England in the current context.